VALIANTLABNSEVALIANT LABORATORIES LTDHighNeutral
Announced Mon, 10 Aug, 2026 · 20:21 IST

Valiant Labs Q1 FY27 results: revenue up 44% YoY, net profit jumps 5x

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDFExplain this filing

VALIANTLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+5.0%Reaction day
₹67.81
prior close
₹71.20
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.2%+5.2% vs market

On the reaction day the stock moved 5.2 pts more than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs market
Reaction day
+5.0-0.2+5.2
Next day
+10.2+0.2+10.0
2d
+15.7+0.4+15.4
3d
+21.5+0.4+21.1
4d
+27.6+0.6+27.1
5d
+34.0+0.9+33.0
1w
+34.9+0.9+34.1
15d
+35.0+0.9+34.1
1m
+89.5+2.3+87.2
2m
+74.2-1.1+75.3
3m
———
UpDownMarket · Nifty Microcap 250Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Valiant Laboratories reported Q1 FY27 audited results. Standalone revenue from operations rose to Rs 7,342.11 lakhs, up about 44% YoY from Rs 5,100.73 lakhs. Net profit surged to Rs 947.68 lakhs from Rs 181.56 lakhs, a roughly 5x jump. EPS stood at Rs 1.75 versus Rs 0.42. On consolidated basis, revenue grew to Rs 11,528.51 lakhs and net profit to Rs 2,110.30 lakhs with EPS of Rs 3.89. Auditor Raman S. Shah and Co issued an unqualified opinion. No exceptional items reported.

Likely market impact

Strong profit growth well ahead of revenue growth signals margin expansion. Clean audit opinion supports earnings credibility for shareholders.